Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Krystal Biotech, Inc. (KRYS) vs Bio-Techne Corp (TECH)

Krystal Biotech, Inc. and Bio-Techne Corp are both Biotechnology companies. Bio-Techne Corp is the larger, with a market value of $11.4B against $10.2B — 1.1× the size. Krystal Biotech, Inc. trades at the lower P/E: 41.9× against 62.1×. Krystal Biotech, Inc. grew revenue faster over the last twelve months: 22.6% against −0.38%. Krystal Biotech, Inc. has the higher net margin (54.8% vs 15.0%) and the higher return on invested capital (24.1% vs 7.70%). Across the 21 metrics below, Krystal Biotech, Inc. leads on 15 and Bio-Techne Corp on 6.

Valuation

Metric KRYS TECH Biotechnology median
P/E 41.86 62.06 7.88
P/S 23.21 9.32 11.47
P/B 7.52 5.37 2.52
Price to free cash flow 39.65 43.02 21.16
EV/EBITDA 45.87 32.27 0.74
EV/Sales 21.29 9.28 10.73
Earnings yield 2.39% 1.61% (28.84%)
Free cash flow yield 2.52% 2.32% (23.03%)

Profitability

Metric KRYS TECH Biotechnology median
Gross margin 94.64% 65.77% 65.16%
Operating margin 44.89% 20.73% 0.00%
Net margin 54.82% 14.97% 0.00%
Free cash flow margin 58.52% 21.66% 0.00%
Return on equity 20.12% 9.03% (57.72%)
Return on assets 18.30% 7.07% (49.22%)
Return on invested capital 24.07% 7.70% 0.00%

Growth

Metric KRYS TECH Biotechnology median
Revenue growth (TTM) 22.63% (0.38%) 5.64%
EPS growth (last fiscal year) 128.00% 152.17% —
Revenue growth, 5-year CAGR — 5.47% 8.40%
Net income growth, 5-year CAGR 0.00% 5.31% 0.00%

Health

Metric KRYS TECH Biotechnology median
Debt to equity 0.00 0.09 0.00
Current ratio 8.32 4.55 4.73
Net debt to EBITDA (4.93) (0.19) 0.96

Dividend

Metric KRYS TECH Biotechnology median
Dividend yield — 0.37% 2.10%
Payout ratio 0.00 0.18 0.00

Size

Metric KRYS TECH Biotechnology median
Market cap 10.21b 11.38b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack